Sanofi (SNY) Stock Highlights

47.71 | +0.44%

2024-12-21 00:09:04

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the companys decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firms footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Statistics

Range Today

46.89 47.9

Volume Today 2.37M

Range 1 Year

45.22 58.97

Volume 1 Year 520.98M

Range 3 Year

36.91 58.97

Volume 3 Year 1.59B

Range 10 Year

36.81 58.97

Volume 10 Year 4.64B

Highlights

Market Capitalization 121.31B (large)

Floating Shares 1.1B

Current Price 47.71

Price To Earnings 24.83

Price To Revenue 1.58

Price To Book 0.82

Earnings Per Share 1.89

Dividend Yield 4.29%

Dividend Per Share 2.04

Payout Ratio 104.79%

Performance

Latest +0.44%

1 Month -0.5%

3 Months -17.67%

6 Months +1.73%

1 Year -2.29%

3 Years -2.77%

5 Years -5.11%

10 Years +3.16%

Benchmarks

Market Capitalization

0 / 14

Gross Profits

0 / 14

Total Revenue

0 / 14

Total Rank

0 / 14

Free Cashflow

0 / 14

Performance 5 years

0 / 14

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.